ALERGOLOGÍA
Instituto de Investigación Biomédica de Salamanca
Salamanca, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Biomédica de Salamanca (120)
2024
-
Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings
International Journal of Clinical Pharmacy
-
PTEN hamartoma tumor syndrome: Clinical and genetic characterization in pediatric patients
Child's Nervous System
2023
-
A Prospective Study of Costs Associated With the Evaluation of Allergic Reactions to Radiological Contrast Media
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 102-108
-
ALERGODATA: Sentinel Registry of Health Outcomes in Allergic Patients Treated With Biological Therapies at Specialized Allergology Clinics in Spain
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 479-482
-
Biological treatments for asthma
The Dangers of Allergic Asthma (Nova Science Publishers, Inc.), pp. 265-283
-
Cardioprotective function of sclerostin by reducing calcium deposition, proliferation, and apoptosis in human vascular smooth muscle cells
Cardiovascular Diabetology, Vol. 22, Núm. 1
-
Contact Palpebral Dermatitis and Conjunctivitis Due to Delayed Hypersensitivity to Timolol
Dermatitis
-
Correspondence regarding the paper “Laorden D, Zamarrón E, Romero D, Domínguez-Ortega J, Villamañán E, Losantos I, Gayá F, Quirce S, Álvarez-Sala R. Evaluation of FEOS score and super-responder criteria in a real-life cohort treated with anti-IL5/IL5R. Respir. Med. 2023; 211: 107216”
Respiratory Medicine
-
In-depth blood immune profiling of Good syndrome patients
Frontiers in Immunology, Vol. 14
-
Interleukin 5 Receptor Subunit Alpha Expression as a Potential Biomarker in Patients with Nasal Polyposis
Biomedicines, Vol. 11, Núm. 7
-
Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk
Cells, Vol. 12, Núm. 15
-
Management of Patients with Suspected or Confirmed Antibiotic Allergy: Executive Summary of Guidelines from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 95-101
-
Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 181-186
-
Quantitative and qualitative methods of evaluating response to biologics in severe asthma patients: Results from a real-world study
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 3, pp. 949-951.e2
-
RNY3 modulates cell proliferation and IL13 mRNA levels in a T lymphocyte model: a possible new epigenetic mechanism of IL-13 regulation
Journal of Physiology and Biochemistry, Vol. 79, Núm. 1, pp. 59-69
-
Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature
International Journal of Immunopathology and Pharmacology, Vol. 37
-
Response to Monoclonal Antibodies in Asthma: Definitions, Potential Reasons for Failure, and Therapeutic Options for Suboptimal Response
Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 1, pp. 1-13
-
The Importance of Preventing and Managing Tear Dysfunction Syndrome in Allergic Conjunctivitis and How to Tackle This Problem
Journal of Investigational Allergology and Clinical Immunology, Vol. 33, Núm. 6, pp. 439-445
-
The therapeutic potential of neurofibromin signaling pathways and binding partners
Communications Biology, Vol. 6, Núm. 1
-
Transcriptomics reveals new regulatory mechanisms involved in benralizumab response
Allergy: European Journal of Allergy and Clinical Immunology